Skip to main content

Table 2 Hazard ratio (HR) for all-cause 30-day or 1-year mortality of SHR, ABG and HbA1C in the whole cohort

From: Prognostic significance of the stress hyperglycemia ratio and admission blood glucose in diabetic and nondiabetic patients with spontaneous intracerebral hemorrhage

Variables

30-day mortality

 

1-year mortality

Unadjusted model

 

Adjusted model d

 

Unadjusted model

 

Adjusted model e

HR(95% CI)

p value

p-trend

 

HR(95% CI)

p value

p-trend

HR(95% CI)

p value

p-trend

 

HR(95% CI)

p value

p-trend

SHR

               

Continuous variable

per unit

3.41 (2.64,4.40)

< 0.001

  

2.78 (2.00,3.86)

< 0.001

  

2.65 (2.10,3.33)

< 0.001

  

2.00 (1.52,2.64)

< 0.001

 

Quantile a

  

< 0.001

   

< 0.001

   

< 0.001

   

< 0.001

Q1 (n = 205)

Ref

       

Ref

      

Q2 (n = 204)

0.96 (0.53,1.72)

0.884

  

1.03 (0.57,1.88)

0.920

  

0.93 (0.63,1.37)

0.698

  

0.96 (0.64,1.44)

0.851

 

Q3 (n = 209)

1.59 (0.94,2.68)

0.084

  

1.63 (0.94,2.82)

0.080

  

1.28 (0.89,1.85)

0.179

  

1.26 (0.86,1.84)

0.233

 

Q4 (n = 204)

1.78 (1.06,2.98)

0.028

  

1.88 (1.08,3.27)

0.027

  

1.19 (0.82,1.73)

0.356

  

1.23 (0.82,1.83)

0.315

 

Q5 (n = 206)

3.95 (2.48,6.31)

< 0.001

  

3.33 (2.01,5.51)

< 0.001

  

2.49 (1.78,3.48)

< 0.001

  

2.09 (1.46,3.00)

< 0.001

 

ABG

               

Continuous variable

per unit

1.01 (1.00,1.02)

< 0.001

  

1.00 (1.00,1.01)

< 0.001

  

1.01 (1.00,1.02)

< 0.001

  

1.01 (1.00,1.01)

< 0.001

 

Quantile b

  

< 0.001

   

< 0.001

   

< 0.001

   

< 0.001

Q1 (n = 206)

Ref

       

Ref

      

Q2 (n = 215)

0.73 (0.42,1.30)

0.289

  

0.81 (0.45,1.46)

0.484

  

0.91 (0.62,1.33)

0.613

  

1.06 (0.71,1.56)

0.789

 

Q3 (n = 197)

1.65 (1.02,2.70)

0.043

  

1.35 (0.89,2.31)

0.119

  

1.09 (0.75,1.60)

0.641

  

1.27 (0.85,1.89)

0.243

 

Q4 (n = 208)

1.92 (1.20,3.07)

0.006

  

1.58 (0.96,2.59)

0.073

  

1.57 (1.11,2.22)

0.011

  

1.29 (0.90,1.86)

0.171

 

Q5 (n = 202)

2.51 (1.59,3.97)

< 0.001

  

2.21 (1.37,3.57)

0.001

  

1.97 (1.40,2.77)

< 0.001

  

1.79 (1.26,2.54)

0.001

 
  1. a SHR: Q1 (≤ 0.863), Q2 (0.863–0.978), Q3 (0.978–1.112), Q4 (1.112–1.314), Q5 (>1.314)
  2. b Glucose: Q1 (≤ 99.4), Q2 (99.4–116), Q3 (116–134), Q4 (134–167), Q5 (>167)
  3. c HbA1C: Q1 (≤ 5.3), Q2 (5.3–5.6), Q3 (5.6–5.9), Q4 (5.9–6.6), Q5 (>6.6)
  4. d Adjusted model was adjusted for the variables with a p value < 0.01 in the univariable Cox regression, including gender, age, heart rate, mean arterial pressure, respiratory rate, body temperature, SpO2, Glasgow Coma Scale, white blood cell count, neutrophil percentage, lymphocyte percentage, hemoglobin, red blood cell distribution width, serum calcium, serum sodium, creatinine, blood urea nitrogen, aspartate aminotransferase, and bilirubin
  5. e Adjusted model was adjusted for the variables with a p value < 0.01 in the univariable Cox regression, including gender, age, myocardial infarct, congestive heart failure, renal disease, heart rate, mean arterial pressure, respiratory rate, body temperature, SpO2, Glasgow Coma Scale, white blood cell count, lymphocyte percentage, hemoglobin, red blood cell distribution width, serum calcium, serum sodium, creatinine, blood urea nitrogen, aspartate aminotransferase, bilirubin, and prothrombin time